
2025-03-07 IB
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy yog ib txoj hauv kev kho mob qog noj ntshav tshiab ua ke nrog kev phais mob me me nrog tus kheej chemoimmunotherapy xa ncaj qha mus rau hauv cov qog. Txoj kev no tsom mus rau kev kho kom zoo tshaj plaws thaum txo qis cov kev mob tshwm sim, uas ua rau cov neeg mob tau txais txiaj ntsig zoo dua. Kab lus no qhia txog cov ntsiab lus ntawm cov txheej txheem no, suav nrog nws cov hauv paus ntsiab lus, cov txheej txheem, cov txiaj ntsig, thiab cov lus qhia yav tom ntej.
Intratumoral chemoimmunotherapy cuam tshuam ncaj qha txhaj tshuaj chemotherapeutic agents thiab/los yog immunotherapeutic agents rau hauv cov qog. Qhov kev xa tawm hauv cheeb tsam no tso cai rau cov tshuaj ntau dua kom mus txog qhov chaw qog, txo qis kev raug mob thiab tshuaj toxicity piv rau cov tshuaj tua kab mob hauv lub cev. Nws feem ntau siv nrog rau lwm yam kev kho mob xws li kev phais lossis kev kho hluav taws xob.
Kev kho mob qog noj ntshav ib txwm muaj, xws li kev siv tshuaj tua kab mob thiab kev kho hluav taws xob, feem ntau cuam tshuam rau tag nrho lub cev, ua rau muaj kev phiv loj heev. Intratumoral therapy sawv cev rau kev hloov mus rau ntau lub hom phiaj thiab tus kheej txoj hauv kev. Los ntawm kev tsom mus rau kev kho mob ncaj qha rau cov qog, nws lub hom phiaj txhawm rau khaws cov ntaub so ntswg noj qab haus huv thiab txhim kho tus neeg mob lub neej zoo. Shandong Baofa Cancer Research Institute tau cog lus rau innovation nyob rau hauv daim teb no.
Qhov 'Ultra-Minimum Incision' nam yog hais txog cov txheej txheem phais siv los nkag rau cov qog rau kev txhaj tshuaj. Qhov no feem ntau cuam tshuam nrog me me incisions, feem ntau coj los ntawm kev yees duab yees xws li ultrasound lossis CT scans, kom paub meej tias tus neeg mob tau txais kev kho mob. Qhov cuam tshuam tsawg kawg nkaus ntawm cov txheej txheem ua rau lub sijhawm rov qab sai dua thiab txo qhov mob tom qab phais.
Personalization yog ib qho tseem ceeb ntawm txoj hauv kev no. Ua ntej kev kho mob, tus neeg mob lub qog raug tshuaj xyuas los txheeb xyuas nws cov yam ntxwv tshwj xeeb, xws li kev hloov caj ces thiab cov cim tiv thaiv kab mob. Cov ntaub ntawv no yog siv los xaiv cov kws khomob zoo tshaj plaws thiab cov tshuaj tiv thaiv kab mob rau cov qog nqaij hlav. Txoj kev ua tus kheej no ua rau kom muaj txoj hauv kev zoo tshaj plaws ntawm kev kho mob thiab txo qhov kev pheej hmoo ntawm kev tsis zoo.
Biomarker tsom xam yog qhov tseem ceeb rau tus kheej chemoimmunotherapy. Los ntawm kev txheeb xyuas cov biomarkers tshwj xeeb hauv cov qog, cov kws kho mob tuaj yeem kwv yees seb cov tshuaj twg zoo tshaj plaws. Piv txwv li, PD-L1 kev qhia tuaj yeem qhia tau tias muaj peev xwm teb tau rau qee yam kev tiv thaiv kab mob.
Cov Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy txheej txheem feem ntau muaj cov kauj ruam hauv qab no:
Txoj hauv kev tshiab no muaj ntau yam txiaj ntsig zoo piv rau kev kho mob qog noj ntshav ib txwm:
Thaum kev tshawb fawb tseem tab tom ua, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy tau pom cov lus cog tseg hauv kev kho ntau yam mob qog noj ntshav, suav nrog:
Ntau qhov kev sim tshuaj ntsuam xyuas tseem tab tom soj ntsuam kev nyab xeeb thiab kev ua tau zoo ntawm Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Cov txiaj ntsig thaum ntxov tau cog lus tseg, nrog qee qhov kev tshawb fawb qhia pom cov qog nqaij hlav tseem ceeb thiab txhim kho cov ciaj sia nyob hauv cov neeg mob kho nrog txoj hauv kev no. Piv txwv li, ib qho kev tshawb fawb luam tawm nyob rau hauv lub Phau ntawv Journal of Clinical Oncology pom tau tias muaj kev txhim kho tseem ceeb hauv kev ciaj sia tag nrho rau cov neeg mob uas muaj melanoma siab heev kho nrog intratumoral immunotherapy piv rau cov kws kho mob nrog cov tshuaj tua kab mob. [1].
Lub teb ntawm intratumoral chemoimmunotherapy yog sai heev. Cov lus qhia yav tom ntej muaj xws li:
Tsis yog txhua tus neeg mob yog cov neeg sib tw tsim nyog rau Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Tej yam uas yuav tau xav txog muaj xws li:
Kev ntsuam xyuas tag nrho los ntawm ntau pab neeg ntawm oncologists, kws phais neeg, thiab lwm tus kws kho mob tshwj xeeb yog qhov tseem ceeb los txiav txim seb qhov kev kho mob no puas tsim nyog rau ib tus neeg mob. Cov neeg mob nrhiav cov ntaub ntawv ntxiv yog txais tos hu rau peb rau kev sab laj thawj zaug.
Ib yam li txhua txoj kev kho mob, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy muaj qee qhov kev pheej hmoo thiab muaj feem cuam tshuam. Cov no yuav suav nrog:
Nws yog ib qho tseem ceeb uas yuav tau tham txog cov kev pheej hmoo no nrog koj tus kws kho mob ua ntej kev kho mob.
Tus nqi ntawm Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy tuaj yeem sib txawv nyob ntawm cov tshuaj siv tshwj xeeb, qhov nyuaj ntawm cov txheej txheem, thiab qhov chaw ntawm qhov chaw kho mob. Nws yog ib qho tseem ceeb los tham txog cov nqi nrog koj tus kws kho mob thiab lub tuam txhab pov hwm. Kev nkag mus tau kuj tseem yog qhov tseem ceeb, vim tias qhov kev kho mob no tseem tsis tau muaj nyob hauv txhua lub chaw kho mob qog noj ntshav.
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy sawv cev rau txoj kev cog lus tshiab rau kev kho mob qog noj ntshav. Los ntawm kev sib txuas cov kev phais me me nrog rau tus kheej chemoimmunotherapy, nws muaj peev xwm txhim kho kev ua tau zoo, txo cov tshuaj lom, thiab txhim kho tus neeg mob lub neej zoo. Thaum xav tau kev tshawb fawb ntxiv, txoj hauv kev tshiab no tau cog lus zoo rau yav tom ntej ntawm kev kho mob qog noj ntshav. Ntawm Shandong Baofa Cancer Research Institute, peb nyob twj ywm rau siab ntso ua pioneering kev kho mob cancer thiab muab cov neeg mob nrog kev saib xyuas zoo tshaj plaws. Tiv tauj peb kom paub ntau ntxiv txog peb cov kev xaiv kho mob qog noj ntshav.
[1] Ribas, A., et al. (2018). Intratumoral Immunotherapy. Phau ntawv Journal of Clinical Oncology, 36(9), 919-927.